FDA Drug Application (020552) for COVERA-HS by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number020552
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BC Extended-release dosage forms (capsules, injectables and tablets)
Reference Drug
Drug NameCOVERA-HS
Active IngredientVERAPAMIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient VERAPAMIL HYDROCHLORIDE10


Back to FDA Applications sponsored by GD SEARLE LLC